PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKI) COMPOUNDS TO THE EYE - Patent 2178564

(19)

(11)

EP 2 178 564 A1

(12)

(43)	Date of publication:
	28.04.2010 Bulletin 2010/17

(21)	Application number: 06851209.4

(22)	Date of filing: 20.07.2007

(51)

International Patent Classification (IPC):

A61K 47/10^(2006.01)
A61K 9/10^(2006.01)

A61K 31/416^(2006.01)

(86)	International application number:
	PCT/US2006/062359

(87)	International publication number:
	WO 2009/014510 (29.01.2009 Gazette 2009/05)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
	Designated Extension States:
	AL BA HR MK RS

(71)	Applicant: Alcon, Inc.
	6331 Hünenberg (CH)

(72)	Inventors:
	HAN, Wesley, Wehsin Arlington, TX 76006 (US) JANI, Rajni Fort Worth, TX 76109 (US) ZHANG, Huixiang Fort Worth, TX 76137 (US)

(74)	Representative: Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
	Leopoldstrasse 4 80802 München 80802 München (DE)

(54)	PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKI) COMPOUNDS TO THE EYE